← Back to all trials
Completed
NCT05636332
The Intrepid Clinical Engineering Study
Conditions: Sudden Cardiac Arrest
Sex: All
Ages: 29 Days – 89 Years
Healthy volunteers: 1
Phase: NA
Enrollment: 60
Sponsor: Philips Clinical & Medical Affairs Global
Location: United States
Summary
The purpose of this research study is to collect clinical data to validate a software update for 12-lead electrocardiogram monitoring.
Eligibility Criteria
Inclusion Criteria:Able to read, write, speak, and understand EnglishAge: 29 days to 89 yearsWilling and able to provide informed consent and complete study proceduresWilling to have Philips representatives present during study procedures.Exclusion Criteria:Known allergy to medical adhesives, silicone, or latex (per self-report)Any limitation or medical condition, including but not limited to physical or cognitive disability, that would affect the participant's ability to complete study activities (per investigator)At the time of enrollment, current enrollment in any other interventional research studyAn employee, or residing family member of an employee, of a company that designs, sells, or manufactures monitor/defibrillator technology or related products (including Philips)
Source: ClinicalTrials.gov (NCT05636332). StuddyBuddy aggregates publicly available trial information.